SBIO 股價走勢圖
SBIO 股票價格預測
ALPS Medical Breakthroughs ETF
$61.37
0.86%
$0.52
截至今日：Jun 25, 16:14:43 GMT-4
返回
ALPS Medical Breakthroughs ETF (SBIO) 股票價格預測
SBIO 股價預測摘要
SBIO stock price ended at $61.3 on 星期四, after rising 0.76%
On the latest trading day Jun 25, 2026, the stock price of SBIO rose by 0.76%, climbing from $60.80 to $61.30. Throughout the session, the stock experienced a volatility of 3.74%, with prices fluctuating between a daily low of $60.50 and a high of $62.76. Alongside this price increase, trading volume also rose by 44.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 35.0K shares were traded, amounting to a market value of approximately $176.3M.
SBIO 技術面訊號
技術面訊號摘要
Strong Sell
Sell
Neutral
Buy
Strong Buy
SBIO 目前顯示 4 個買入訊號與 3 個賣出訊號。該股票自 12:00 AM 以來一直處於 上升趨勢 狀態，在此期間價格總共變動了 15.1%。整體而言，技術指標顯示中期後市趨勢為 Buy。
SBIO 的看漲／看跌訊號
我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為SBIO生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。
關鍵數據
前收市價
$60.84
開盤價
$61.4
當日範圍
$60.5 - $62.73
52週區間
$29.33 - $61.37
交易量
46.3K
平均成交量
28.8K
股息收益率
--
淨資產
$0
資產淨值
--
費用率
--
流通中的股數
2.8M
什麼是 SBIO？
SBIO was created on 2014-12-31 by ALPS. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 153.24m in AUM and 83 holdings. SBIO tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials.
